Human papillomavirus (HPV), the most common cause of sexually transmitted infection in the US, can lead to cancer of the cervix, anus, or oropharynx. The HPV vaccine reduces risk of HPV infection and could prevent more than 25,000 cases of cancer per year among US adolescents. In this talk, Dr. Aragones discusses HPV and his research on programs to increase vaccination rates, particularly among minority and immigrant populations most burdened by the disease. (Presented on 4/25/17)
Update: On October 5, 2018, the US Food and Drug Administration announced that it had expanded the approved use of the Gardasil 9 vaccine to include women and men aged 27 through 45 years. “Today’s approval represents an important opportunity to help prevent HPV-related diseases and cancers in a broader age range,” said Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, when making the announcement.